Veradigm - 26 Year Stock Price History | MDRX
- The all-time high Veradigm stock closing price was 45.70 on March 09, 2000.
- The Veradigm 52-week high stock price is 11.80, which is 156.5% above the current share price.
- The Veradigm 52-week low stock price is 3.00, which is 34.8% below the current share price.
- The average Veradigm stock price for the last 52 weeks is 6.90.
Veradigm Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 5.1321 | 9.1000 | 9.7500 | 3.9000 | 4.6000 | -52.82% |
2024 | 9.1198 | 10.7500 | 11.2500 | 5.9900 | 9.7500 | -7.05% |
2023 | 13.4220 | 17.2200 | 19.5900 | 9.5100 | 10.4900 | -40.53% |
2022 | 17.9518 | 18.6100 | 23.0900 | 13.8500 | 17.6400 | -4.39% |
2021 | 16.2178 | 14.3300 | 18.7800 | 13.1900 | 18.4500 | 27.77% |
2020 | 8.7316 | 9.6900 | 14.6100 | 5.0200 | 14.4400 | 47.05% |
2019 | 10.4970 | 9.7800 | 12.2100 | 8.7600 | 9.8200 | 1.87% |
2018 | 12.8046 | 14.9800 | 16.0300 | 8.6400 | 9.6400 | -33.75% |
2017 | 12.7107 | 10.9300 | 14.9100 | 10.5300 | 14.5500 | 42.51% |
2016 | 12.7938 | 14.4300 | 14.6500 | 10.0000 | 10.2100 | -33.62% |
2015 | 13.4710 | 12.8500 | 15.5300 | 11.6100 | 15.3800 | 20.44% |
2014 | 15.1701 | 15.3900 | 19.4300 | 11.2300 | 12.7700 | -17.40% |
2013 | 13.7477 | 9.4100 | 16.2600 | 9.3700 | 15.4600 | 64.12% |
2012 | 13.4261 | 18.3100 | 21.4700 | 8.9900 | 9.4200 | -50.26% |
2011 | 19.4391 | 19.5700 | 22.7100 | 14.4900 | 18.9400 | -1.71% |
2010 | 18.4029 | 20.3800 | 22.4100 | 15.7700 | 19.2700 | -4.75% |
2009 | 14.6468 | 9.9700 | 22.1300 | 7.8500 | 20.2300 | 103.93% |
2008 | 6.9148 | 9.9949 | 11.1000 | 4.6547 | 9.9200 | -3.87% |
2007 | 13.2071 | 14.2511 | 16.4669 | 9.1022 | 10.3191 | -28.05% |
2006 | 10.7473 | 7.3594 | 15.3510 | 7.3594 | 14.3415 | 101.42% |
2005 | 7.8874 | 5.4837 | 9.9524 | 4.9735 | 7.1203 | 25.59% |
2004 | 4.4460 | 2.9384 | 5.8716 | 2.7950 | 5.6696 | 100.57% |
2003 | 1.9295 | 1.1956 | 3.1775 | 1.0308 | 2.8268 | 122.58% |
2002 | 1.9543 | 1.7216 | 3.5282 | 1.0096 | 1.2700 | -26.23% |
2001 | 2.7958 | 3.9354 | 6.1937 | 1.1690 | 1.7216 | -65.32% |
2000 | 16.4471 | 27.6308 | 45.6971 | 3.1882 | 4.9649 | -78.76% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.498B | $0.588B |
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $45.855B | 58.34 |
Tempus AI (TEM) | United States | $12.773B | 0.00 |
Doximity (DOCS) | United States | $12.199B | 54.27 |
Hims & Hers Health (HIMS) | United States | $10.301B | 85.22 |
IRhythm Technologies (IRTC) | United States | $5.159B | 0.00 |
Hinge Health (HNGE) | United States | $4.608B | 0.00 |
Privia Health (PRVA) | United States | $2.610B | 193.36 |
Inspire Medical Systems (INSP) | United States | $2.596B | 38.16 |
Phreesia (PHR) | United States | $1.708B | 0.00 |
Enovis (ENOV) | United States | $1.689B | 8.93 |
10x Genomics (TXG) | United States | $1.645B | 0.00 |
Omnicell (OMCL) | United States | $1.456B | 28.04 |
Schrodinger (SDGR) | United States | $1.422B | 0.00 |
Azenta (AZTA) | United States | $1.393B | 60.78 |
Clover Health Investments (CLOV) | United States | $1.358B | 0.00 |
Claritev (CTEV) | United States | $1.180B | 0.00 |
Evolent Health (EVH) | United States | $1.092B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.491B | 0.00 |
Standard BioTools (LAB) | United States | $0.467B | 0.00 |
Talkspace (TALK) | United States | $0.429B | 128.00 |
Carlsmed (CARL) | $0.360B | 0.00 | |
Butterfly Network (BFLY) | United States | $0.360B | 0.00 |
TruBridge (TBRG) | United States | $0.289B | 50.74 |
Outset Medical (OM) | United States | $0.236B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.235B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.212B | 0.00 |
Health Catalyst (HCAT) | United States | $0.205B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.193B | 0.00 |
CapsoVision (CV) | United States | $0.178B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.135B | 0.00 |
American Well (AMWL) | United States | $0.115B | 0.00 |
CareCloud (CCLD) | United States | $0.110B | 5.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
Insight Molecular Diagnostics (IMDX) | United States | $0.069B | 0.00 |
Pulmonx (LUNG) | United States | $0.064B | 0.00 |
111 (YI) | China | $0.058B | 0.00 |
P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
HeartBeam (BEAT) | United States | $0.035B | 0.00 |
Precipio (PRPO) | United States | $0.024B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.023B | 0.00 |
Zhongchao (ZCMD) | China | $0.023B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
HeartSciences (HSCS) | United States | $0.008B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
PROFUSA (PFSA) | United States | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |